Logo image of ESIGM.MI

ESI SPA (ESIGM.MI) Stock Fundamental Analysis

Europe - BIT:ESIGM - IT0005421885 - Common Stock

1.445 EUR
-0.08 (-5.56%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

5

Overall ESIGM gets a fundamental rating of 5 out of 10. We evaluated ESIGM against 43 industry peers in the Construction & Engineering industry. Both the profitability and the financial health of ESIGM get a neutral evaluation. Nothing too spectacular is happening here. ESIGM is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ESIGM was profitable.
ESIGM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ESIGM reported negative net income in multiple years.
In multiple years ESIGM reported negative operating cash flow during the last 5 years.
ESIGM.MI Yearly Net Income VS EBIT VS OCF VS FCFESIGM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

The Return On Assets of ESIGM (3.45%) is worse than 60.47% of its industry peers.
ESIGM has a Return On Equity of 28.89%. This is in the better half of the industry: ESIGM outperforms 67.44% of its industry peers.
With an excellent Return On Invested Capital value of 21.87%, ESIGM belongs to the best of the industry, outperforming 86.05% of the companies in the same industry.
Industry RankSector Rank
ROA 3.45%
ROE 28.89%
ROIC 21.87%
ROA(3y)-1.53%
ROA(5y)2.18%
ROE(3y)-12.46%
ROE(5y)-1.13%
ROIC(3y)N/A
ROIC(5y)N/A
ESIGM.MI Yearly ROA, ROE, ROICESIGM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a decent Profit Margin value of 6.70%, ESIGM is doing good in the industry, outperforming 62.79% of the companies in the same industry.
ESIGM's Profit Margin has declined in the last couple of years.
ESIGM's Operating Margin of 11.88% is fine compared to the rest of the industry. ESIGM outperforms 74.42% of its industry peers.
In the last couple of years the Operating Margin of ESIGM has grown nicely.
ESIGM has a worse Gross Margin (34.36%) than 60.47% of its industry peers.
ESIGM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.88%
PM (TTM) 6.7%
GM 34.36%
OM growth 3Y21.12%
OM growth 5YN/A
PM growth 3Y-11.84%
PM growth 5YN/A
GM growth 3Y-3.75%
GM growth 5YN/A
ESIGM.MI Yearly Profit, Operating, Gross MarginsESIGM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 100 150

4

2. Health

2.1 Basic Checks

ESIGM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, ESIGM has more shares outstanding
ESIGM has a better debt/assets ratio than last year.
ESIGM.MI Yearly Shares OutstandingESIGM.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ESIGM.MI Yearly Total Debt VS Total AssetsESIGM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ESIGM has an Altman-Z score of 1.09. This is a bad value and indicates that ESIGM is not financially healthy and even has some risk of bankruptcy.
ESIGM has a worse Altman-Z score (1.09) than 83.72% of its industry peers.
ESIGM has a debt to FCF ratio of 2.20. This is a good value and a sign of high solvency as ESIGM would need 2.20 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.20, ESIGM is doing good in the industry, outperforming 72.09% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that ESIGM is not too dependend on debt financing.
ESIGM's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. ESIGM outperforms 72.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.2
Altman-Z 1.09
ROIC/WACC2.94
WACC7.45%
ESIGM.MI Yearly LT Debt VS Equity VS FCFESIGM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 1.09 indicates that ESIGM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.09, ESIGM perfoms like the industry average, outperforming 53.49% of the companies in the same industry.
ESIGM has a Quick Ratio of 1.09. This is a bad value and indicates that ESIGM is not financially healthy enough and could expect problems in meeting its short term obligations.
ESIGM has a Quick ratio of 0.25. This is amonst the worse of the industry: ESIGM underperforms 97.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.25
ESIGM.MI Yearly Current Assets VS Current LiabilitesESIGM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

7

3. Growth

3.1 Past

ESIGM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 464.58%, which is quite impressive.
Measured over the past years, ESIGM shows a very strong growth in Earnings Per Share. The EPS has been growing by 115.72% on average per year.
Looking at the last year, ESIGM shows a very negative growth in Revenue. The Revenue has decreased by -50.38% in the last year.
ESIGM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 146.66% yearly.
EPS 1Y (TTM)464.58%
EPS 3Y115.72%
EPS 5YN/A
EPS Q2Q%-45.97%
Revenue 1Y (TTM)-50.38%
Revenue growth 3Y146.66%
Revenue growth 5YN/A
Sales Q2Q%-25.86%

3.2 Future

Based on estimates for the next years, ESIGM will show a decrease in Earnings Per Share. The EPS will decrease by -2.61% on average per year.
ESIGM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.71% yearly.
EPS Next Y-17.5%
EPS Next 2Y-2.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.2%
Revenue Next 2Y25.09%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ESIGM.MI Yearly Revenue VS EstimatesESIGM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ESIGM.MI Yearly EPS VS EstimatesESIGM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

ESIGM is valuated correctly with a Price/Earnings ratio of 13.14.
Based on the Price/Earnings ratio, ESIGM is valued a bit cheaper than the industry average as 65.12% of the companies are valued more expensively.
ESIGM is valuated cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 3.47 indicates a rather cheap valuation of ESIGM.
100.00% of the companies in the same industry are more expensive than ESIGM, based on the Price/Forward Earnings ratio.
ESIGM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 13.14
Fwd PE 3.47
ESIGM.MI Price Earnings VS Forward Price EarningsESIGM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ESIGM is valued cheaply inside the industry as 88.37% of the companies are valued more expensively.
ESIGM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.4
EV/EBITDA 4.11
ESIGM.MI Per share dataESIGM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

A cheap valuation may be justified as ESIGM's earnings are expected to decrease with -2.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ESIGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ESI SPA

BIT:ESIGM (10/14/2025, 7:00:00 PM)

1.445

-0.08 (-5.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.88M
Analysts84.44
Price Target2.55 (76.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.14
Fwd PE 3.47
P/S 0.62
P/FCF 11.4
P/OCF 4.92
P/B 2.68
P/tB 3.1
EV/EBITDA 4.11
EPS(TTM)0.11
EY7.61%
EPS(NY)0.42
Fwd EY28.85%
FCF(TTM)0.13
FCFY8.77%
OCF(TTM)0.29
OCFY20.34%
SpS2.33
BVpS0.54
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 28.89%
ROCE 35.44%
ROIC 21.87%
ROICexc 40.33%
ROICexgc 48.88%
OM 11.88%
PM (TTM) 6.7%
GM 34.36%
FCFM 5.45%
ROA(3y)-1.53%
ROA(5y)2.18%
ROE(3y)-12.46%
ROE(5y)-1.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y165.8%
ROICexcg growth 5YN/A
ROICexc growth 3Y183.53%
ROICexc growth 5YN/A
OM growth 3Y21.12%
OM growth 5YN/A
PM growth 3Y-11.84%
PM growth 5YN/A
GM growth 3Y-3.75%
GM growth 5YN/A
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.2
Debt/EBITDA 0.49
Cap/Depr 299.6%
Cap/Sales 7.18%
Interest Coverage 250
Cash Conversion 88.42%
Profit Quality 81.28%
Current Ratio 1.09
Quick Ratio 0.25
Altman-Z 1.09
F-Score6
WACC7.45%
ROIC/WACC2.94
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)8.34%
Cap/Sales(5y)20.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)464.58%
EPS 3Y115.72%
EPS 5YN/A
EPS Q2Q%-45.97%
EPS Next Y-17.5%
EPS Next 2Y-2.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.38%
Revenue growth 3Y146.66%
Revenue growth 5YN/A
Sales Q2Q%-25.86%
Revenue Next Year8.2%
Revenue Next 2Y25.09%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y206.06%
EBIT growth 3Y198.75%
EBIT growth 5YN/A
EBIT Next Year13.94%
EBIT Next 3Y15.12%
EBIT Next 5YN/A
FCF growth 1Y169.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y248.36%
OCF growth 3Y52.91%
OCF growth 5YN/A